Evidence map›Paper›PMID 29069972›Full record

ArticleJournal of the renin-angiotensin-aldosterone system : JRAAS

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism.

Kathryn M Meurs, Joshua A Stern, Clarke E Atkins, Darcy Adin, Brent Aona, Julia Condit, Teresa DeFrancesco, Yamir Reina-Doreste, Bruce W Keene, Sandy Tou and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the renin-angiotensin-aldosterone system : JRAAS. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The Role of Personalized Medicine in Companion Animal Cardiology.The Veterinary clinics of North America. Small animal practice · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The renin-angiotensin-aldosterone system and its suppression.Journal of veterinary internal medicine · 2019
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Kathryn M MeursDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Joshua A SternDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Clarke E AtkinsDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Darcy AdinDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Brent AonaDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Julia ConditDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Teresa DeFrancescoDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Yamir Reina-DoresteDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Bruce W KeeneDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Sandy TouDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Jessica WardDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
Kathleen WoodruffDepartment of Veterinary Clinical Sciences, North Carolina State University, USA.
North Carolina State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objective of this study was to evaluate angiotensin-converting enzyme (ACE) activity in dogs and with and without an ACE polymorphism in the canine ACE gene, before and after treatment with an ACE inhibitor.

methodsThirty-one dogs (20 wild-type, 11 ACE polymorphism) with heart disease were evaluated with ACE activity measurement and systolic blood pressure before and after administration of an ACE inhibitor (enalapril).

resultsMedian pre-treatment ACE activity was significantly lower for ACE polymorphism dogs than for dogs with the wild-type sequence ( P=0.007). After two weeks of an ACE inhibitor, ACE activity was significantly reduced for both genotypes (wild-type, P<0.0001; ACE polymorphism P=0.03); mean post-therapy ACE activity was no different between the groups.

conclusionAn ACE polymorphism is associated with lower levels of ACE activity. Dogs with the polymorphism still experience suppression of ACE activity in response to an ACE inhibitor. It is possible that the genetic status and ACE activity of dogs may impact the response of dogs with this variant to an ACE inhibitor.

Indexed as

Polymorphism, GeneticAngiotensin-Converting Enzyme InhibitorsAnimalsBreedingDogsGenotypeHeart DiseasesPeptidyl-Dipeptidase AAngiotensin-Converting Enzyme InhibitorsPeptidyl-Dipeptidase Aangiotensin-converting enzymecanineenalaprilPolymorphism

Identifiers

PMID29069972
PMCPMC5843865
OpenAlexW2790461664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.